BREAKING NEWS  – Rapid detection of antibiotic resistance in down to 2 hours on primary clinical sample – BREAKING NEWS 

Executive Director of MOLSID Showcases Product Pipeline at ESCMID GLOBAL Conference

It was a pleasure for MOLSID, represented by its Executive Director Younes Lazrak, to present our product pipeline at this year’s ESCMID GLOBAL. Many thanks go to BEAM ALLIANCE for the invitation to the pipeline corner and to Till Bachman for organising the session. Younes Lazrak and our CSA Jens Hasserodt truly enjoyed meeting up […]

Molsid develop the first truly rapid test for AMR in primary clinical samples

How about you? Do you contribute to the containment of Antimicrobial Resistance that threats us all? We at Molsid do our part. We develop the first truly rapid test for AMR in primary clinical samples. That’s why we are an official contender for the Longitude Prize that calls for just such a test that’s rapid first and foremost, […]

DRIBA project

« DRIBA », project by VETOPHAGE, Molsid and École normale supérieure de Lyon, funded by Région Auvergne-Rhône-Alpes with the support of Bpifrance, will develop the first kit for the detection of the pathogenic bacterium S.aureus and of the presence of antibiotic resistance for bovine mastitis. Bovine mastitis, a bacterial infection of cows’ udders, affects 40% of the 3.7 million dairy cows in France each […]

Molsid new corporate website

MOLSID is happy to announce the launch of its new corporate website. Visit us at and learn more about our PYTHIA project. Thank you to Abyxo Team for your great work!

Molsid nominated for the 2019 Innovation Awards

Linked to Molsid participation to the Lab’Startup Village at the next Forum Labo exhibition in Paris, the company has been nominated for the 2019 Innovation Awards with a possibility to win the French Startup Trophy. The award ceremony will take place on Tuesday March 26.   >> Read more


Molsid est fière de faire partie des premiers lauréats de l’appel à manifestation d’intérêt (AMI) du Grand Défi (PIA4) « Nouvelles biothérapies et outils de production » en tant que partenaire du projet « SCANBioM2 » dont bioMérieux est le coordinateur. Le 4è PIA (PIA4) est doté de 20 Md€ d’engagements sur la période 2021-2025, dont 11 Md€ contribueront à […]

ISO 9001:2015 certification

We at Molsid are proud to announce the ISO 9001:2015 certification of our management system, as approved by DEKRA. This certification has been achieved through stringent adherence to operating standards by our team. It covers the development, production and commercialisation of our fluorogenic molecular probes and kits. We constantly aim at improving our products and […]

Molsid has been awarded the European SEAL OF EXCELLENCE

The Molsid Team has recently presented a major innovative R&D project to the European Commission which has been noted 14.1 out of 15 points. The result was Molsid being awarded the European « SEAL OF EXCELLENCE ».